AZN AstraZeneca PLC

NASDAQ
$166.58

AstraZeneca PLC (AZN) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is $2.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.1% since its last earnings release on July 27, 2026.

AstraZeneca PLC Beat Consensus Estimates, Reaffirms
Monday, July 27, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:00 AM ET
Earnings Whisper
-
vs $2.17
Rev est $16.07B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $162.42

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AstraZeneca PLC

AstraZeneca PLC is a biopharmaceutical company. It is engaged in the discovery and development of new products, which are then manufactured, marketed and sold.

Sector

Healthcare

Industry

Drug Manufacturers / Major

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.